Rescue-antagonist avoidance and estradiol-decline-guided early oocyte retrieval after spontaneous LH elevation in women with diminished ovarian reserve: a multicenter retrospective cohort study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background In women with diminished ovarian reserve (DOR), managing spontaneous luteinizing hormone (LH) elevation during antagonist-free ovarian stimulation presents a clinical dilemma, and the optimal post-elevation strategy remains unclear. We compared an integrated strategy combining rescue-antagonist avoidance with empirically scheduled early oocyte retrieval against rescue GnRH antagonist administration followed by fixed-time retrieval. Methods This multicenter retrospective cohort study included 936 unique-patient in vitro fertilization or intracytoplasmic sperm injection cycles from three reproductive medicine centers between January 2020 and January 2025. Eligible patients had DOR (AMH < 1.1 ng/mL and/or AFC < 7), underwent antagonist-free stimulation, and developed first documented spontaneous LH elevation ≥ 10 mIU/mL before planned retrieval; time zero (T0) was defined as the first detection of LH ≥ 10 mIU/mL. In both strategies, hCG for final oocyte maturation was administered on the day of T0 once the post-LH-elevation strategy had been selected. In the rescue-antagonist control strategy, cetrorelix 0.25 mg was administered subcutaneously daily from T0 until hCG, and retrieval was scheduled at approximately 36 h after hCG. In the integrated strategy, rescue antagonist was withheld; E2 was remeasured the day after hCG, and retrieval was scheduled at approximately 26, 29, or 35 h after hCG according to prespecified empirical E2-decline categories (> 50%, 33%–50%, and < 33%). The primary outcome was the number of metaphase II (MII) oocytes; the key secondary outcome was retrieval of at least one MII oocyte. Inverse probability of treatment weighting (IPTW) was used to adjust for measured confounders. Results In the primary complete-case IPTW analysis of 916 cycles, the integrated strategy was associated with a higher MII oocyte count (incidence rate ratio 1.51, 95% confidence interval 1.25–1.82; P < 0.001) and higher odds of MII-positive retrieval (odds ratio 1.82, 95% confidence interval 1.21–2.74; P = 0.003). IPTW-standardized probabilities of retrieving at least one MII oocyte were 74.5% in the integrated group and 60.2% in the control group, an absolute difference of 14.3% points. Results were directionally consistent in sensitivity and per-protocol analyses. Pregnancy and live birth proportions among cycles reaching embryo transfer were similar between groups and are reported only as exploratory post-treatment outcomes. Conclusions An integrated strategy of rescue-antagonist avoidance and empirically timed early retrieval was associated with a higher MII oocyte yield and a greater probability of obtaining at least one MII oocyte than rescue antagonist followed by fixed-time retrieval. These observational findings support the comparative effectiveness of a composite care bundle rather than a specific endocrine mechanism or a validated E2-based timing algorithm. Prospective external validation is required.
Source: BMC Pregnancy and Childbirth
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,290
OpenAlex ID: W7234435026
